本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Kazia Therapeutics Limited

11.19
+0.18001.63%
盤前11.530.3400+3.04%04:00 EDT
成交量:34.08萬
成交額:379.93萬
市值:1.57億
市盈率:-1.64
高:11.43
開:11.10
低:10.83
收:11.01
52周最高:17.40
52周最低:4.86
股本:1,400.69萬
流通股本:1,165.62萬
量比:1.07
換手率:2.92%
股息:- -
股息率:- -
每股收益(TTM):-6.8190
每股收益(LYR):-12.3849
淨資產收益率:-106.90%
總資產收益率:-25.70%
市淨率:4.73
市盈率(LYR):-0.90

資料載入中...

2026/08/19

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/27

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/03/31

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/03/26

SEC問詢函

Form CORRESP - Correspondence
2025/12/23

SEC問詢函

Form CORRESP - Correspondence
2025/12/23

SEC問詢函

Form CORRESP - Correspondence
2025/12/19

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2025/12/19

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2025/11/07

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/09/30

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2025/02/03

SEC問詢函

Form CORRESP - Correspondence
2025/01/30

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/11/15

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/09/11

SEC問詢函

Form CORRESP - Correspondence
2024/08/12

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/07/03

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/06/27

SEC問詢函

Form CORRESP - Correspondence